Claims
- 1. A compound having the formula ##STR9## or a pharmaceutically acceptable salt, ester, amide or prodrug thereof wherein the ester selected from C.sub.1 -to-C.sub.6 alkyl esters, C.sub.5 -to-C.sub.7 cycloalkyl esters and arylalkyl esters and wherein the amide results from reaction of a carboxylic acid moiety in the compound of formula I with NH.sub.3, NH.sub.2 (C.sub.1 -to-C.sub.6 alkyl), NH(C.sub.1 -to-C.sub.6 alkyl).sub.2 or a 5- or 6-membered heterocycle containing one nitrogen atom and wherein the prodrug is selected from the group consisting of (a) acyloxymethyl esters of carboxylic acids, (b) (5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl esters of carboxylic acids, (c) esters derived from alcohol groups In the parent drug by reaction with succinic acid, phosphoric acid, dialkylaminoacetic acid or an amino acid (d) N-Mannich bases of amides or amines, (e) N-hydroxymethyl derivatives of amides, (f) N-acyloxyalkyl derivatives of amides or heterocyclic amines, (g) oxazolidinones derived from ketone groups in the parent drug by reaction with 2-aminoethanol, N-methyl-2-aminoethanol, N-(2-hydroxyethyl)-2-aminoethanol, 2-aminopropanol, 2-amino-2-methylpropanol, 2-amino-2-hydroxymethylpropanol, 3-amino-2-hydroxypropane, 2-amino-1-phenylethanol, 3-aminopropanol or N-methyl-2-amino-1-phenylpropanol and (h) enol esters derived from ketone groups In the parent drug, wherein
- n is an integer between one and three;
- R is selected from the group consisting of methyl, ethyl, allyl and propyl;
- R.sup.102 is hydrogen and R.sup.103 is selected from the group consisting of hydrogen, hydroxy and protected hydroxy wherein the hydroxy protecting group is selected from methylthiomethyl, dimethylthexylsilyl, tri(C.sub.1 -to-C.sub.8 -alkyl)silyl, C.sub.1 -to-C.sub.8 -alkyldiarylsilyl, triarylsilyl, tri(aryl-C.sub.1 -to-C.sub.12 -alkyl)silyl, C.sub.1 -to-C.sub.12 -alkyl-C(O)-, aryl-C(O)-, C.sub.1 -to-C.sub.8 -alkyl-O-C(O)-, C.sub.1 -to-C.sub.8 -alkyl-S(O).sub.2 - and aryl-S(O).sub.2 -, or, taken together, R.sup.102 and R.sup.103 form a bond;
- R.sup.104 is selected from the group consisting of hydrogen, hydroxy and protected hydroxy independently defined as above;
- R.sup.105 and R.sup.106 are selected such that one of R.sup.105 and R.sup.106 is hydrogen and the other is hydroxy, or, taken together, R.sup.105 and R.sup.106 form a divalent radical selected from the group consisting of oxygen and methylene;
- R.sup.107, R.sup.108 and R.sup.110 are each independently selected from the group consisting of hydrogen, methoxy and an azole radical; and
- R.sup.109 is selected from the group consisting of hydrogen and an azole radical, with the provisos that (a) exactly one of R.sup.107, R.sup.108, R.sup.109 and R.sup.110 is an azole radical, (b) exactly one of R.sup.107 and R.sup.108 is hydrogen, and (c) exactly one of R.sup.109 and R.sup.110 is hydrogen;
- where the azole radical is selected from the group consisting of ##STR10## where R.sup.1, R.sup.1 ' and R.sup.1 " are independently selected from the group consisting of
- (i) hydrogen,
- (ii) C.sub.1 -to-C.sub.8 -lower alkyl,
- (iii) C.sub.2 -to-C.sub.8 -lower alkenyl,
- (iv) C.sub.3 -to-C.sub.8 -cycloalkyl,
- (v) C.sub.3 -to-C.sub.8 -cycloalkyl-C.sub.1 -to-C.sub.8 -alkyl,
- (vi) C.sub.3 -to-C.sub.8 -cycloalkyl-C.sub.2 -to-C.sub.12 -alkenyl,
- (vii) nitro,
- (viii) halogen,
- (ix) --C(O)--O--R.sup.4 where R.sup.4 is selected from the group consisting of
- (a) hydrogen,
- (b) C.sub.1 -to-C.sub.8 -lower alkyl, and
- (c) aryl-C.sub.1 -to-C.sub.12 -alkyl,
- (x) mono-, di-, tri-, or perhalogenated C.sub.1 -to-C.sub.8 -loweralkyl,
- (xi) aryl, and
- (xii) aryl-C.sub.1 -to-C.sub.12 -alkyl;
- or, taken together, any two adjacent R.sup.1, R.sup.1 ' and R.sup.1 " and the carbon atoms to which they are attached form a saturated or unsaturated carbocyclic or heterocyclic ring having between five and seven ring atoms;
- R.sup.2 and R.sup.2 ' are independently selected from the group consisting of
- (i) hydrogen,
- (ii) C.sub.1 -to-C.sub.8 -lower alkyl,
- (iii) C.sub.2 -to-C.sub.8 -lower alkenyl,
- (iv) amino,
- (v) C.sub.1 -to-C.sub.8 -alkylamino,
- (vi) aryl-C.sub.1 -to-C.sub.12 -alkylamino,
- (vii) acylamino wherein acyl is C.sub.1 -to-C.sub.12 -C(O)- or aryl-C(O)-,
- (viii) arylamino,
- (ix) C.sub.3 -to-C.sub.8 -cycloalkyl,
- (x) C.sub.3 -to-C.sub.8 -cycloalkyl-C.sub.1 -to-C.sub.8 -alkyl,
- (xi) C.sub.3 -to-C.sub.8 -Cycloalkyl-C.sub.2 -to-C.sub.12 -alkenyl,
- (xii) --C(O)--O--R.sup.4 where R.sup.4 is as described above,
- (xiii) ureido,
- (xiv) aryl,
- (xv) aryl-C.sub.1 -to-C.sub.12 -alkyl,
- (xvi) heterocyclic-C.sub.1 -to-C.sub.12 -alkylamino, and
- (xvii) nitro;
- and R.sup.3 and R.sup.3 ' are independently selected from the group consisting of
- (i) hydrogen,
- (ii) C.sub.1 -to-C.sub.8 -lower alkyl,
- (iii) hydroxy-C.sub.1 -to-C.sub.12 -alkyl,
- (iv) C.sub.1 -to-C.sub.8 -alkoxy-C.sub.1 -to-C.sub.12 -alkyl,
- (v) halogen,
- (vi) cyano-C.sub.1 -to-C.sub.12 -alkyl,
- (vii) acylamino-C.sub.1 -to-C.sub.12 -alkyl wherein acyl is independently defined as above,
- (viii) C.sub.1 -to-C.sub.8 -alkylamino,
- (ix) aryl-C.sub.1 -to-C.sub.12 -alkylamino,
- (x) acylamino wherein acyl is independently defined as above,
- (xi) arylamino,
- (xii) C.sub.3 -to-C.sub.8 -cycloalkyl,
- (xiii) C.sub.3 -to-C.sub.8 -cycloalkyl-C.sub.1 -to-C.sub.8 -alkyl,
- (xiv) aryl, and
- (xv) arylalkyl;
- wherein at each occurrence the term aryl is independently selected from phenyl, 1- or 2-naphthyl, fluorenyl, (1,2)-dihydronaphthyl, (1,2,3,4)-tetrahydronaphthyl, indenyl, indanyl; and wherein at each occurrence the term heterocyclic is independently selected from pyrrolyl, pyrrolidinyl, pyrazolyl, pyrazolinyl, pyrazolidinyl, cytosinyl, thiocytosinyl, imidazolyl, imidazolinyl, imidazolidinyl, pyridyl, piperidinyl, pyrazinyl, piperazinyl, pyrimidinyl, pyridazinyl, xanthenyl, xanthonyl, xanthopterinyl, oxazoyl, oxaxolidinyl, thiouracilyl, isoxaxolyl, isoxazolidinyl, morpholinyl, indolyl, quinolinyl, uracilyl, urazolyl, uricyl, thiazolyl, thiazolidinyl, isothiazolyl, isothiazolldinyl, isoquinolinyl, thyminyl, benzimidazoly, benzothiazolyl, benzoxazolyl, furyl, thienyl and benzothienyl.
- 2. A compound according to claim 1 wherein R is ethyl.
- 3. A compound according to claim 1 wherein R.sup.102 is hydrogen.
- 4. A compound according to claim 1 wherein R.sup.103 is selected from the group consisting of hydrogen and hydroxy.
- 5. A compound according to claim 1 wherein R.sup.103 is protected hydroxy.
- 6. A compound according to claim 1 wherein R.sup.104 is hydrogen or hydroxy.
- 7. A compound according to claim 1 wherein R.sup.105 and R.sup.106, taken together, are oxo.
- 8. A compound according to claim 1 wherein n is one or two.
- 9. A compound according to claim 1 wherein the heterocyclic radical is a 1,2,3-benztriazole radical having the formula: ##STR11## wherein R.sub.1, R.sub.1' and R.sub.1" are as defined therein.
- 10. A compound according to claim 1 wherein the heterocyclic radical is a 1,2,4-triazole radical having the formula: ##STR12## wherein R.sub.2 and R.sub.2' are as defined therein.
- 11. A compound according to claim 10, wherein R.sup.2 and R.sup.2' are each hydrogen.
- 12. A compound according to claim 1 of the formula: ##STR13## wherein R=ethyl; R.sup.102 =H; R.sup.103 =tert-butylidimethylsilyloxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; R.sup.107 =R.sup.109 =H; R.sup.108 =1-(1,2,3-triazolyl); R.sup.110 =methoxy; and n=2;
- R=ethyl; R.sup.102 =H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; R.sup.107 =R.sup.109 =H; R.sup.108 =1-(1,2,3-triazolyl); R.sup.110 =methoxy; and n=2;
- R=ethyl; R.sup.102 =H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; one of R.sup.107 or R.sup.108 =methoxy and the other is hydrogen; one of R.sup.109 or R.sup.110 is 1-(1,2,3-triazolyl) and the other is hydrogen; and n=2;
- R=ethyl; R.sup.102 =H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; R.sup.107 =R.sup.109 =H; R.sup.108 =1-(1,2,3-benzotriazolyl); R.sup.110 =methoxy; and n=2;
- R=ethyl; R.sup.102 =H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; one of R.sup.107 or R.sup.108 =methoxy and the other is hydrogen; one of R.sup.109 or R.sup.110 is 1-(1,2,3-benzotriazolyl) and the other is hydrogen; and n=2;
- R=ethyl; R.sup.102 =H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; R.sup.107 =R.sup.109 =H; R.sup.108 =1-(5-nitro-1,2,3-benzotriazolyl); R.sup.110 =methoxy; and n=2;
- R=ethyl; R.sup.102 =H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; R.sup.107 =R.sup.109 =H; R.sup.108 =1-(6-nitro-1,2,3-benzotriazolyl); R.sup.110 =methoxy; and n=2;
- R=ethyl; R.sup.102 =H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; one of R.sup.107 or R.sup.108 =methoxy and the other is hydrogen; one of R.sup.109 or R.sup.110 is 1-(5-nitro-1,2,3-benzotriazolyl) and the other is hydrogen; and n=2;
- R=ethyl; R.sup.102 =H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; one of R.sup.107 or R.sup.108 =methoxy and the other is hydrogen; one of R.sup.109 or R.sup.110 is 1-(6-nitro-1,2,3-benzotriazolyl) and the other is hydrogen; and n=2;
- R=ethyl; R.sup.102 =H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; R.sup.107 =R.sup.109 =H; R.sup.108 =1-(1,2,4-triazolyl); R.sup.110 =methoxy; and n=2;
- R=ethyl; R.sup.102 =H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; one of R.sup.107 or R.sup.108 =methoxy and the other is hydrogen; one of R.sup.109 or R.sup.110 is 1-(1,2,4-triazolyl) and the other is hydrogen; and n=2;
- T=ethyl; R.sup.102 =H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; R.sup.107 =R.sup.109 =H; R.sup.108 =1-(3-nitro-1,2,4-triazolyl); R.sup.110 =methoxy; and n=2;
- R=ethyl; R.sup.102 =H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; one of R.sup.107 or R.sup.108 =methoxy and the other is hydrogen; one of R.sup.109 or R.sup.110 is 1-(3-nitro-1,2,4-triazolyl) and the other is hydrogen; and n=2;
- R=ethyl; R.sup.102 =H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; R.sup.107 =R.sup.109 =H; R.sup.108 =1-(5,6-dimethyl-1,2,3-benzotriazolyl); R.sup.110 =methoxy; and n=2;
- R=ethyl; R.sup.102 =H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; one of R.sup.107 or R.sup.108 =methoxy and the other is hydrogen; one of R.sup.109 or R.sup.110 is 1-(5,6-dimethyl-1,2,3-benzotriazolyl) and the other is hydrogen; and n=2;
- R=ethyl; R.sup.102 =H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; R.sup.107 =R.sup.109 =H; R.sup.108 =1-(5-chloro-1,2,3-benzotriazolyl); R.sup.110 =methoxy; and n=2;
- R=ethyl; R.sup.102 =H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; R.sup.107 =R.sup.109 =H; R.sup.108 =1-(6-chloro-1,2,3-benzotriazolyl); R.sup.110 =methoxy; and n=2;
- R=ethyl; R.sup.102 =H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; one of R.sup.107 or R.sup.108 =methoxy and the other is hydrogen; one of R.sup.109 or R.sup.110 is 1-(5-chloro-1,2,3-benzotriazolyl) and the other is hydrogen; and n=2;
- R=ethyl; R.sup.102 =H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; one of R.sup.107 or R.sup.108 =methoxy and the other is hydrogen; one of R.sup.109 or R.sup.110 is 1-(6-chloro-1,2,3-benzotriazolyl) and the other is hydrogen; and n=2;
- R=ethyl; R.sup.102 =H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; R.sup.107 =R.sup.109 =H; R.sup.108 =1-(5-carboxy-1,2,3-benzotriazolyl); R.sup.110 =methoxy; and n=2;
- R=ethyl; R.sup.102 =H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; R.sup.107 =R.sup.109 =H; R.sup.108 =1-(6-carboxy-1,2,3-benzotriazolyl); R.sup.110 =methoxy; and n=2;
- R=ethyl; R.sup.102 H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; one of R.sup.107 or R.sup.108 =methoxy and the other is hydrogen; one of R.sup.109 or R.sup.110 is 1-(5-carboxy-1,2,3-benzotriazolyl) and the other is hydrogen; and n=2;
- R=ethyl; R.sup.102 =H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; one of R.sup.107 or R.sup.108 =methoxy and the other is hydrogen; one of R.sup.109 or R.sup.110 is 1-(6-carboxy-1,2,3-benzotriazolyl) and the other is hydrogen; and n=2;
- R=ethyl; R.sup.102 =H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; R.sup.107 =R.sup.109 =H; R.sup.108 =1-(5-trifluoromethyl-1,2,3-benzotriazolyl); R.sup.110 =methoxy; and n=2;
- R=ethyl; R.sup.102 =H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; R.sup.107 =R.sup.109 =H; R.sup.108 =1-(6-trifluoromethyl-1,2,3-benzotriazolyl); R.sup.110 =methoxy; and n=2;
- R=ethyl; R.sup.102 =H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; one of R.sup.107 or R.sup.108 =methoxy and the other is hydrogen; one of R.sup.109 or R.sup.110 is 1-(5-trifluoromethyl-1,2,3-benzotriazolyl) and the other is hydrogen; and n=2;
- R=ethyl; R.sup.102 =H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; one of R.sup.107 or R.sup.108 =methoxy and the other is hydrogen; one of R.sup.109 or R.sup.110 is 1-(6-trifluoromethyl-1,2,3-benzotriazolyl) and the other is hydrogen; and n=2;
- R=ethyl; R.sup.102 =H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; R.sup.107 =R.sup.109 =H; R.sup.108 =1-(3-amino-1,2,4-triazolyl); R.sup.110 =methoxy; and n=2;
- R=ethyl; R.sup.102 =H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; one of R.sup.107 or R.sup.108 =methoxy and the other is hydrogen; one of R.sup.109 or R.sup.110 is 1-(3-amino-1,2,4-triazolyl) and the other is hydrogen; and n=2;
- R=ethyl; R.sup.102 =H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; R.sup.107 =R.sup.109 =H; R.sup.108 =1-(3-amino-5-carboxy-1,2,4-triazolyl); R.sup.110 =methoxy; and n=2;
- R=ethyl; R.sup.102 =H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; one of R.sup.107 or R.sup.108 =methoxy and the other is hydrogen; one of R.sup.109 or R.sup.110 is 1-(3-amino-5-carboxy-1,2,4-triazolyl) and the other is hydrogen; and n=2;
- R=ethyl; R.sup.102 =H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; R.sup.107 =R.sup.109 =H; R.sup.108 =1-(3-[N-maleimide]-1,2,4-triazolyl); R.sup.110 =methoxy; and n=2;
- R=ethyl; R.sup.102 =H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; one of R.sup.107 or R.sup.108 =methoxy and the other is hydrogen; one of R.sup.109 or R.sup.110 is 1-(3-[N-maleimide]-1,2,4-triazolyl) and the other is hydrogen; and n=2;
- R=ethyl; R.sup.102 =H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; R.sup.107 =R.sup.109 =H; R.sup.108 =1-(3-phenyl-5-ureido-1,2,4-triazolyl); R.sup.110 =methoxy; and n=2;
- R=ethyl; R.sup.102 =H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; one of R.sup.107 or R.sup.108 =methoxy and the other is hydrogen; one of R.sup.109 or R.sup.110 is 1-(3-phenyl-5-ureido-1,2,4-triazolyl) and the other is hydrogen; and n=2;
- R=ethyl; R.sup.102 =H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; R.sup.107 =R.sup.109 =H; R.sup.108 =1-(3-[3-pyridylmethylamino]-1,2,4-triazolyl); R.sup.110 =methoxy; and n=2;
- R=ethyl; R.sup.102 =H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; one of R.sup.107 or R.sup.108 =methoxy and the other is hydrogen; one of R.sup.109 or R.sup.110 is 1-(3-[3-pyridylmethylamino]-1,2,4-triazolyl) and the other is hydrogen; and n=2;
- R=ethyl; R.sup.102 =H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; R.sup.107 =R.sup.109 =H; R.sup.108 =1-(4-methyl-1,2,3-benzotriazolyl); R.sup.110 =methoxy; and n=2;
- R=ethyl; R.sup.102 =H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; one of R.sup.107 or R.sup.108 =methoxy and the other is hydrogen; one of R.sup.109 or R.sup.110 is 1-(4-methyl-1,2,3-benzotriazolyl) and the other is hydrogen; and n=2;
- R=ethyl; R.sup.102 =H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; R.sup.107 =R.sup.109 =H; R.sup.108 =1-(3-methylamino-5-phenyl-1,2,4-triazolyl); R.sup.110 =methoxy; and n=2; and
- R=ethyl; R.sup.102 =H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; one of R.sup.107 or R.sup.108 =methoxy and the other is hydrogen; one of R.sup.109 or R.sup.110 is 1-(3-methylamino-5-phenyl-1,2,4-triazolyl) and the other is hydrogen; n=2.
- 13. A compound according to claim 1 of the formula: ##STR14## R=ethyl; R.sup.102 =H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; R.sup.107 =R.sup.109 =H; R.sup.108 =1-(1,2,3-triazolyl); R.sup.110 =methoxy; and n=2;
- R=ethyl; R.sup.102 =H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; one of R.sup.107 or R.sup.108 =methoxy and the other is hydrogen; one of R.sup.109 or R.sup.110 is 1-(1,2,3-triazolyl) and the other is hydrogen; and n=2;
- R=ethyl; R.sup.102 =H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; R.sup.107 =R.sup.109 =H; R.sup.108 =1-(1,2,3-benzotriazolyl); R.sup.110 =methoxy; and n=2;
- R=ethyl; R.sup.102 =H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; one of R.sup.107 or R.sup.108 =methoxy and the other is hydrogen; one of R.sup.109 or R.sup.110 is 1-(1,2,3-benzotriazolyl) and the other is hydrogen; and n=2;
- R=ethyl; R.sup.102 =H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; R.sup.107 =R.sup.109 =H; R.sup.108 =1-(5-nitro-1,2,3-benzotriazolyl); R.sup.110 =methoxy; and n=2;
- R=ethyl; R.sup.102 =H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; R.sup.107 =R.sup.109 =H; R.sup.108 =1-(5-nitro-1,2,3-benzotriazolyl); R.sup.110 =methoxy; and n=2;
- R=ethyl; R.sup.102 =H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; R.sup.107 =R.sup.109 =H; R.sup.108 =1-(6-nitro-1,2,3-benzotriazolyl); R.sup.110 =methoxy; and n=2;
- R=ethyl; R.sup.102 =H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; one of R.sup.107 or R.sup.108 =methoxy and the other is hydrogen; one of R.sup.109 or R.sup.110 is 1-(5-nitro-1,2,3-benzotriazolyl) and the other is hydrogen; and n=2;
- R=ethyl; R.sup.102 =H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; one of R.sup.107 or R.sup.108 =methoxy and the other is hydrogen; one of R.sup.109 or R.sup.110 is 1-(6-nitro-1,2,3-benzotriazolyl) and the other is hydrogen; and n=2;
- R=ethyl; R.sup.102 =H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; R.sup.107 =R.sup.109 =H; R.sup.108 =1-(1,2,4-triazolyl); R.sup.110 =methoxy; and n=2;
- R=ethyl; R.sup.102 =H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; one of R.sup.107 or R.sup.108 =methoxy and the other is hydrogen; one of R.sup.109 or R.sup.110 is 1-(1,2,4-triazolyl) and the other is hydrogen; and n=2;
- R=ethyl; R.sup.102 =H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; R.sup.107 =R.sup.109 =H; R.sup.108 =1-(3-nitro-1,2,4-triazolyl); R.sup.110 =methoxy; and n=2; and
- R=ethyl; R.sup.102 =H; R.sup.103 =hydroxy; R.sup.104 =H; R.sup.105 and R.sup.106 taken together form an oxo; one of R.sup.107 or R.sup.108 =methoxy and the other is hydrogen; one of R.sup.109 or R.sup.110 is 1-(3-nitro-1,2,4-triazolyl) and the other is hydrogen; and n=2.
- 14. A pharmaceutical composition useful for immunomodulation, comprising a therapeutically effective amount of a compound according to claim 1 in combination with a pharmaceutically acceptable carrier.
- 15. A pharmaceutical composition useful for immunomodulation, comprising a therapeutically effective amount of a compound according to claim 10 in combination with a pharmaceutically acceptable carrier.
- 16. A pharmaceutical composition useful for immunomodulation, comprising a therapeutically effective amount of a compound according to claim 13 in combination with a pharmaceutically acceptable carrier.
- 17. A method of producing immunomodulation in a patient in need of such treatment, comprising administering to the patient a therapeutically effective amount of a compound according to claim 1.
- 18. A method of producing immunomodulation in a patient in need of such treatment, comprising administering to the patient a therapeutically effective amount of a compound according to claim 10.
- 19. A method of producing immunomodulation in a patient in need of such treatment, comprising administering to the patient a therapeutically effective amount of a compound according to claim 13.
Parent Case Info
This application is a continuation of U.S. patent application Ser. No. 08/212,473, filed Mar. 14, 1994, abandoned, which is a continuation-in-part of U.S. patent application Ser. No. 08/032,958, filed Mar. 17, 1993, which is a continuation-in-part of International Patent Application No. PCT/US92/07600, filed Sep. 8, 1992, which is a continuation-in-part of U.S. patent application Ser. No. 07/755,208, filed Sep. 5, 1991 and now abandoned.
US Referenced Citations (2)
Number |
Name |
Date |
Kind |
5208241 |
Ok et al. |
May 1993 |
|
5262533 |
Sinclair et al. |
Nov 1993 |
|
Foreign Referenced Citations (2)
Number |
Date |
Country |
0428365 |
May 1991 |
EPX |
WO9220688 |
Nov 1992 |
WOX |
Continuations (1)
|
Number |
Date |
Country |
Parent |
212473 |
Mar 1994 |
|
Continuation in Parts (2)
|
Number |
Date |
Country |
Parent |
32958 |
Mar 1993 |
|
Parent |
755208 |
Sep 1991 |
|